SCMM

(redirected from Sequenom Center for Molecular Medicine)
AcronymDefinition
SCMMStandard Chartered Mumbai Marathon (Mumbai, India)
SCMMSo Call Me Maybe (song)
SCMMSequenom Center for Molecular Medicine (Grand Rapids, MI)
SCMMStanding Committee on Military Matters
SCMMSoCal MINI Maniacs (Los Angeles, CA)
SCMMSoftware Capability Maturity Model
SCMMSociete Commerciale des Metaux et Minerais
SCMMSoftware Configuration Management Manager
References in periodicals archive ?
Sequenom landed the deal through its fully-owned subsidiary lab Sequenom Center for Molecular Medicine LLC, which has developed the MaterniT21 PLUS laboratory-developed test (LDT) for fetal chromosomal abnormalities.
Life sciences company Sequenom Inc (NASDAQ:SQNM) and its wholly owned subsidiary, Sequenom Center for Molecular Medicine (Sequenom CMM), have entered into technology licensing and marketing agreements with Laboratoire Cerba in France, Sequenom announced today.
3 June 2011 -- US lender Silicon Valley Bank, a unit of SVB Financial Group (NASDAQ:SIVB), has made a commitment for up to USD30m (EUR20.7m) in financing for Sequenom Center for Molecular Medicine and its parent, US life sciences firm Sequenom (NASDAQ: SQNM), the latter announced Thursday.
This international distribution was initiated by the company's wholly-owned subsidiary, the Sequenom Center for Molecular Medicine (Sequenom CMM).
[1] Sequenom Center for Molecular Medicine and [2] Sequenom, Inc., San Diego, CA; * address correspondence to this author at: Sequenom, Inc., 3595 John Hopkins Ct., San Diego, CA 92121.
Sequenom Center for Molecular Medicine (Sequenom CMM), a unit of Sequenom Inc, is a molecular diagnostics laboratory accredited by the College of American Pathologists (CAP) and certified by the Clinical Laboratory Improvement Amendments (CLIA).